Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1177 related articles for article (PubMed ID: 16890276)

  • 1. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
    Schmidt AM; Imesch P; Fink D; Egger H
    Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
    Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary pelvic exenteration in cervical cancer patients.
    Ungar L; Palfalvi L; Novak Z
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pelvic exenteration, morbidity and survival].
    Méndez L; Bernal A; Escudero P; González G; Fajardo A
    Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma.
    Houvenaeghel G; Lelievre L; Gonzague-Casabianca L; Buttarelli M; Moutardier V; Goncalves A; Resbeut M
    Gynecol Oncol; 2006 Feb; 100(2):338-43. PubMed ID: 16213008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].
    Janser JC; Rodier JF; Rodier D; Vergnes Y
    Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
    Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
    Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for locally recurrent rectal cancer.
    Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
    Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
    Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
    Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.